What is Salusive Health's primary value proposition for doctors?

According to slide 4, the primary value proposition is a financial one: the platform enables physicians to generate an additional $65,000 in revenue per year. This is likely achieved through Medicare reimbursement codes for remote patient monitoring, which the company supports via its Medicare licensing mentioned on slide 5.

How does Salusive Health demonstrate product-market fit?

The company demonstrates product-market fit through its traction metrics. Slide 5 and slide 6 both highlight $77,000 in 'Signed MRR.' For a startup in an accelerator batch, this level of committed monthly revenue suggests significant early adoption and a scalable sales process within the healthcare sector.

What regulatory milestones has the company achieved?

Salusive Health highlights two major milestones on slide 5: a patent filing with the USPTO in November 2015 and becoming 'Medicare Licensed' in February 2018. The latter is critical in the US healthcare market, as it allows providers to bill the government for services rendered through the platform.

What specific health metrics does the platform monitor?

Based on the product screenshot on slide 3, the platform monitors several key vitals including Blood Pressure (BP), Glucose, SPO2 (oxygen saturation), Weight, and Heart Rate (HR). The interface also includes a 'High Risk' alert system and a visual 'Patient Chart' to track these metrics over time.

Is there information about the founding team in the deck?

No, the provided slides do not include a team slide. While the contact email 'waleed@salusive.com' appears on several slides, there are no biographies, headshots, or descriptions of the founders' backgrounds or previous experience in healthcare or technology.

Salusive Health Pitch Deck (2018): 11-Slide Seed Deck

See all 11 slides of the Salusive Health pitch deck — a 2018 deck — with a slide-by-slide teardown of what the deck does well and where it falls short.

Salusive Health's pitch deck, presented at 500 Startups Demo Day Batch 23, is a masterclass in minimalist design tailored for a rapid-fire presentation environment. By stripping away dense text and focusing on three core pillars—clinical outcomes, physician revenue, and regulatory milestones—the company makes a compelling case for its remote patient monitoring platform. The deck reports a substantial $77K in signed Monthly Recurring Revenue (MRR) and a $13 billion market opportunity. While it lacks traditional slides for team biographies, competition, and specific use of funds, it successfull…

Key takeaways

The company claims to improve patient outcomes by +33% as stated on slide 6.
Salusive Health reports a significant traction milestone of $77K in signed MRR on slide 5.
The platform offers a clear financial incentive for providers, claiming +$65k/yr in revenue per physician on slide 4.
Regulatory and legal moats are established with a patent filed in November 2015 and Medicare licensing in February 2018 (slide 5).
The total addressable market is defined as a $13B market opportunity on slide 6.
The deck utilizes a minimalist visual style with almost no body text, relying on large-scale metrics to drive the narrative.
There is a complete absence of a team slide, competitive analysis, or a specific financial 'ask' in the provided slides.
The product interface is briefly showcased on slide 3, highlighting a 'Patient Chart' with vital sign tracking for BP, Glucose, and SPO2.

The Demo Day Format: Minimalism as a Strategy

Salusive Health’s deck is a quintessential example of a Demo Day presentation. In these environments, founders typically have between two and four minutes to speak. Consequently, the slides are not meant to be read; they are meant to be felt. The heavy reliance on large-font numbers and simple iconography suggests that the speaker provided the context while the slides provided the 'proof points.' This teardown examines the six slides provided from their 11-slide deck.

Slide 1: The Vision Statement

The title slide sets a clear, altruistic tone: "Helping physicians improve patient outcomes." It features a high-resolution image of a smiling physician, which immediately identifies the target user. The branding is consistent, featuring the Salusive Health logo and the '500 Batch 23' identifier. This slide does not explain how they help, but it establishes the who and the why immediately.

Slide 2: The Problem of Physician Bandwidth

Slide 2 uses iconography to illustrate a bottleneck. We see a physician in the center, flanked by patients on the left (represented by 15-minute clock icons) and patients on the right (represented by phone icons). This visually communicates the struggle of modern medicine: the inability to manage both in-person visits and the constant stream of remote inquiries. It sets the stage for a solution that automates or streamlines these interactions.

Slide 3: The Solution in Action

The third slide introduces the product. It shows a nurse or medical assistant on the phone while looking at the Salusive Health dashboard. The dashboard itself is the most information-dense part of the deck. It reveals a 'Patient Chart' for a 'Linda Evanston' and shows tracking for BP, Glucose, SPO2, Weight, and HR. The presence of an 'All Activity History' log and a 'Modify Alerts' button suggests a proactive remote monitoring system rather than a passive record-keeping tool.

Slide 4: The Economic Hook

This is the 'money slide.' In massive white text against a blue background, it reads: "+$65k/yr Revenue per Physician." This is a powerful B2B sales argument. In the US healthcare system, physicians are often squeezed by declining reimbursements. By promising a specific, high-dollar increase in annual revenue, Salusive Health moves from being a 'nice-to-have' clinical tool to a 'must-have' business tool. This likely refers to the CPT codes for Remote Patient Monitoring (RPM) that Medicare began paying for around the time this deck was produced.

Slide 5: The Timeline of De-risking

Slide 5 is a horizontal timeline that serves to de-risk the investment. It lists three critical milestones: November 2015: Patent filed (Intellectual Property protection), February 2018: Medicare Licensed (Regulatory approval and reimbursement eligibility), and $77K Signed MRR (Commercial traction). By placing these in a sequence, the company shows a logical progression from idea to legality to revenue.

Slide 6: The Summary of Impact

The final slide in this set acts as a summary of the company’s three strongest pillars. First, the clinical impact: +33% Improved Patient Outcomes . Second, the current momentum: $77K Signed MRR . Third, the ceiling: $13B Market Opportunity . This slide effectively answers the three questions every investor has: Does it work? Is anyone buying it? How big can it get?

What Works Well in This Deck

The most successful element of this deck is its clarity of value . Many health-tech startups get bogged down in the technicalities of HIPAA compliance or the complexities of EHR integration. Salusive Health ignores those in the slides, focusing instead on the fact that they make doctors money and improve patient health. The use of "Signed MRR" is a specific and honest way to report traction, distinguishing between 'expected' revenue and 'contracted' revenue.

The visual consistency is also notable. The blue and white color palette is synonymous with the healthcare industry, conveying a sense of cleanliness and professional trust. By keeping the slides nearly empty, the founders ensure that the audience's attention remains on the speaker, using the slides only to anchor the most important figures in the listener's mind.

What Is Missing

Because this is a Demo Day deck, several standard components are missing, which a founder would need to include in a full 'send-ahead' deck:

Team Slide: There is no mention of the founders' expertise. In digital health, having a mix of clinical experience and technical prowess is vital. · Competition: The remote patient monitoring space is crowded with players like Livongo and Omada. This deck does not address how Salusive Health stays ahead of them. · Unit Economics: While we see the revenue per physician, we don't see the cost of acquisition (CAC) or the churn rate of these contracts. · The Ask: The deck ends without stating how much capital they are raising or what that capital will be used for (e.g., hiring more sales reps vs. R&D).

Lessons for Founders

Founders should copy the "One Big Number" approach used on slides 4 and 5. If you have a metric that is undeniably impressive—like $77K MRR for an early-stage startup—give it its own slide. Don't hide your best facts in a bulleted list. Additionally, the way Salusive Health framed their regulatory milestone ("Medicare Licensed") as a business enabler rather than a hurdle is a sophisticated way to present compliance to investors.

Finally, the deck demonstrates the importance of outcome-oriented messaging . Instead of saying "We have a dashboard with five vitals," they say "We improve outcomes by 33%." Always lead with the result, not the feature.

Frequently asked questions

What is Salusive Health's primary value proposition for doctors?: According to slide 4, the primary value proposition is a financial one: the platform enables physicians to generate an additional $65,000 in revenue per year. This is likely achieved through Medicare reimbursement codes for remote patient monitoring, which the company supports via its Medicare licensing mentioned on slide 5.
How does Salusive Health demonstrate product-market fit?: The company demonstrates product-market fit through its traction metrics. Slide 5 and slide 6 both highlight $77,000 in 'Signed MRR.' For a startup in an accelerator batch, this level of committed monthly revenue suggests significant early adoption and a scalable sales process within the healthcare sector.
What regulatory milestones has the company achieved?: Salusive Health highlights two major milestones on slide 5: a patent filing with the USPTO in November 2015 and becoming 'Medicare Licensed' in February 2018. The latter is critical in the US healthcare market, as it allows providers to bill the government for services rendered through the platform.
What specific health metrics does the platform monitor?: Based on the product screenshot on slide 3, the platform monitors several key vitals including Blood Pressure (BP), Glucose, SPO2 (oxygen saturation), Weight, and Heart Rate (HR). The interface also includes a 'High Risk' alert system and a visual 'Patient Chart' to track these metrics over time.
Is there information about the founding team in the deck?: No, the provided slides do not include a team slide. While the contact email 'waleed@salusive.com' appears on several slides, there are no biographies, headshots, or descriptions of the founders' backgrounds or previous experience in healthcare or technology.

Cover slide of the Salusive Health pitch deck — 2018 — Salusive Health pitch deck, slide 1 (2018)

Salusive Health pitch deck: the facts

Company: Salusive Health
Year: 2018
Stage: Seed (500 Startups Batch 23)
Slides: 11
Sector: Digital Health / Remote Patient Monitoring
Deck type: Demo Day Pitch
Headquarters: United States

Salusive Health pitch deck PDF

The full Salusive Health deck is embedded on this page and can be read slide by slide in the browser — no download or account required. Each slide is covered in the breakdown above.

What the Salusive Health pitch deck was used for

This deck is the 11‑slide Salusive Health presentation used for 500 Startups Batch 23 Demo Day around 2018 at the Seed stage. Salusive Health (later operating as myNurse) positioned itself as a nurse-based, tech-enabled remote patient monitoring and disease management service that helps physician practices improve outcomes and generate additional revenue from Medicare chronic care programs. The deck highlights a $13B market opportunity, specific Medicare reimbursement flows, and $77K in signed monthly recurring revenue, but it does not include a formal fundraising ask slide. At the time, Salusive had been founded in 2015 and was Medicare-licensed by February 2018, which the deck uses as regulatory validation.

Business model: Medicare-accredited, tech-enabled services platform providing nurse-based remote patient monitoring and chronic care management services for physician practices and clinics, typically under a B2B2C model where Salusive’s clinical team and technology support patients between visits while billing Medicare for chronic care and remote monitoring services.

Year: 2018
Investors: 500 Startups (Batch 23 accelerator)
Founded: 2015
Headquarters: Emeryville, California, United States

Round: Seed-stage accelerator participation (500 Startups Batch 23) in 2018, with no publicly disclosed specific seed round amount tied directly to this deck.

Industry: Digital health / remote patient monitoring and chronic care management, combining healthcare services with a technology platform.

What happened after the Salusive Health deck

Salusive Health, founded in 2015 and later operating as myNurse, advanced a Medicare-accredited nurse-based remote patient monitoring and chronic care management model, participated in 500 Startups Batch 23, and grew to meaningful signed MRR with early clinical validation; however, after a security incident disclosed in 2022, the company chose to cease clinical operations by May 31, 2022.

Founded in 2015 as Salusive, Inc., with operations based in Emeryville, California.
Participated in 500 Startups Batch 23 around 2018, presenting this 11-slide Seed-stage deck.
Obtained Medicare accreditation and licensing by February 2018, enabling billing for chronic care and remote monitoring
Operated under the myNurse brand (mynurse.ai), providing AI-assisted remote patient monitoring and chronic care manageme
Reported a data breach discovered on March 7, 2022, involving access to protected health information.
Subsequently decided to cease clinical operations by the end of May 2022, notifying clients and regulators; company stat

What the Salusive Health deck got right

Clear, quantified per-physician economics tied to Medicare reimbursement. The deck presents **specific and sizable unit economics**—Medicare paying $11K per month per physician and $65K additional annual revenue per doctor—making the revenue model concrete and compelling for investors and providers.
Early recurring revenue traction with signed MRR. It highlights **$77K in signed MRR** at the time of the deck, indicating real customer adoption and recurring revenue even at an early Seed stage.
Clinical validation with a brand-name health system partner. The deck leverages a **Sutter Health Innovation Grant study** showing at least 33% improvement in patient outcomes, combining outcome data with a credible health system partner.
Regulatory and reimbursement validation through Medicare accreditation. By emphasizing **Medicare accreditation and licensing** achieved by February 2018, the deck demonstrates that the company has cleared key regulatory hurdles for billing, which is often a major risk in digital health.
High-impact, low-text visual communication tailored for demo day. The presentation uses an **ultra-minimalist, high-impact visual style** that foregrounds market size ($13B), economics, and outcomes instead of dense clinical jargon, which can help keep investor attention in a demo day setting.
Team credibility via strong institutional affiliations. The team slide references affiliations with **Stanford Medicine, Siemens Healthcare, and Microsoft**, signaling a blend of clinical and technical expertise attractive to investors in digital health.

What could have been stronger

No explicit funding ask or round size disclosed. The deck does not include a clear fundraising ask (target amount, valuation range, or planned round size), which makes it harder for investors to immediately understand the capital need and how it links to milestones.
Limited granularity on revenue composition and customer base. While the deck reports $77K signed MRR, it does not break down how much of this comes from a small number of early adopter physicians versus a broader base, limiting visibility into revenue concentration risk and repeatability of sales.
Insufficient detail on reimbursement mechanics and regulatory risk. Although the deck references Medicare paying $11K per month per physician and highlights Medicare licensing, it does not provide detail on coding mix, dependency on specific CMS programs, or reimbursement risk, which are material for a care-management billing model.
Outcome claims lack methodological detail. The deck cites a 33% improvement in patient outcomes from a Sutter Health study but does not specify sample size, duration, or endpoints, which reduces the evidentiary strength of the claimed clinical impact for more rigorous investors.

How an investor would read this deck

What draws attention

High reported **unit economics per physician** (Medicare paying $11K per month per physician and $65K additional annual revenue per doctor) suggest a potentially attractive revenue model if acquisition and support costs are controlled.
Evidence of **regulatory and payer validation**, including Medicare accreditation and licensing by February 2018, de-risks reimbursement feasibility for remote monitoring and chronic care management services.
The **Sutter Health Innovation Grant study** and reported 33% improvement in patient outcomes offer an early clinical proof point and brand-name validation.
Early **signed MRR of $77K** at the time of the deck shows some traction and suggests that physicians are willing to contract for the service.
The team slide references affiliations with organizations like Stanford Medicine, Siemens Healthcare, and Microsoft, which can signal strong technical and clinical credibility.

Risks that stand out

The business is highly dependent on **Medicare reimbursement** for chronic care and remote monitoring services, exposing it to regulatory and fee schedule changes that could significantly alter revenue per physician.
The later reported **data breach** and subsequent shutdown of clinical operations as myNurse highlight operational and security risks in handling sensitive health data, which may retroactively raise concerns about internal controls.
Scaling a **nurse-based service model** can be labor-intensive and may require substantial hiring and management of clinical staff, potentially limiting margins if automation does not keep pace with growth.
The deck’s reliance on a single Sutter Health Innovation Grant study for outcome evidence may indicate limited breadth of validated clinical data at the time, which could constrain adoption by more conservative health systems.

Questions this deck invites

How many physician practices and individual patients contributed to the $77K signed MRR, and what is the churn or retention profile across those early customers?
What specific CPT codes and CMS programs (e.g., chronic care management, remote patient monitoring) underlie the $11K per physician per month figure, and how sensitive is revenue to policy or fee schedule changes?
What were the detailed design, sample size, and outcomes of the Sutter Health Innovation Grant study that reported 33% improvement in patient outcomes, and have results been reproduced in broader deployments?
What are the fully loaded unit economics—including nurse staffing costs, hardware/sensor costs, and acquisition costs—per enrolled patient and per physician practice under the Salusive model?
What governance, security, and compliance measures were in place for handling PHI and how did those evolve over time, especially in light of the later data breach reported in 2022?

What founders can take from the Salusive Health deck

Anchoring a Seed-stage digital health pitch in concrete **Medicare reimbursement flows** (e.g., $11K per month per physician) can make the revenue model tangible and easier for investors to underwrite.
Demonstrating early **clinical validation with a recognizable health system** (such as Sutter Health) is a powerful way to substantiate outcome claims and build credibility in remote patient monitoring.
Showing **specific per-physician economics** (additional annual revenue for doctors plus MRR for the startup) helps align incentives between the company and its provider customers, strengthening the go-to-market story.
An ultra-minimalist, high-impact visual deck can work effectively in healthcare if it keeps financial, regulatory, and clinical proof points front and center rather than dense medical jargon.
Omitting a clear **fundraising ask** can detract from an otherwise strong deck; even compelling traction and validation need to be paired with a precise capital request and milestone plan.
Reliance on health data and Medicare billing underscores the importance of robust **security and compliance** infrastructure; later events like data breaches can materially impact company trajectories even when not directly caused by the initial model.

Salusive Health pitch deck: common questions

What does Salusive Health (myNurse) do?

Salusive Health is a Medicare-accredited, tech-enabled services platform that provides nurse-based remote patient monitoring and chronic care management for physician practices, helping clinics monitor and follow up with patients with chronic conditions between office visits.

What fundraise or event was this Salusive Health deck used for?

The deck was used for 500 Startups Batch 23 Demo Day (Seed stage) around 2018, highlighting Salusive’s chronic care and remote patient monitoring platform, regulatory milestones, and early recurring revenue; it did not explicitly state a target raise amount or valuation.

What traction and financial metrics does the Salusive Health deck highlight?

According to the deck and secondary analyses, Salusive reported a $13B market opportunity, $11K per month in Medicare payments per physician, approximately $65K additional annual revenue per physician, and $77K in signed monthly recurring revenue at the time the deck was created.

What clinical results or outcomes does the deck claim?

The deck cites a study funded by a Sutter Health Innovation Grant, claiming that Salusive improved patient outcomes by at least 33% when patients were connected to Salusive nurses using its technology platform and digital health sensors.

What happened to Salusive Health / myNurse after this deck?

Salusive Health later operated under the myNurse brand and ultimately decided to cease clinical operations following a reported data breach discovered in March 2022; company notices emphasized that the closure decision was not attributed to the breach itself.